China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong · Delayed Price · Currency is HKD 8.48
+0.10 (1.19%)
Jun 1, 2026, 4:08 PM HKT
HKG:2877 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,330 | 6,496 | 7,290 | 5,492 | 5,733 | 5,205 | |
Market Cap Growth | 17.70% | -10.88% | 32.74% | -4.22% | 10.16% | 29.89% |
Enterprise Value | -1,723 | -758 | 967 | 24 | 537 | 224 |
Last Close Price | 8.38 | 8.17 | 8.59 | 6.07 | 5.98 | 5.10 |
PE Ratio | 5.99 | 6.15 | 8.15 | 5.14 | 7.02 | 7.62 |
Forward PE | 5.72 | 7.00 | 6.29 | 5.10 | 7.57 | 6.45 |
PS Ratio | 1.81 | 1.86 | 1.81 | 1.10 | 1.28 | 1.32 |
PB Ratio | 0.71 | 0.72 | 0.92 | 0.71 | 0.80 | 0.72 |
P/TBV Ratio | 0.72 | 0.74 | 0.94 | 0.73 | 0.82 | 0.75 |
P/FCF Ratio | 5.84 | 5.99 | 8.32 | 6.32 | 5.17 | 6.96 |
P/OCF Ratio | 4.85 | 4.98 | 7.11 | 5.35 | 4.57 | 6.03 |
EV/Sales Ratio | - | - | 0.24 | 0.01 | 0.12 | 0.06 |
EV/EBITDA Ratio | - | - | 1.02 | 0.02 | 0.54 | 0.26 |
EV/EBIT Ratio | - | - | 1.09 | 0.02 | 0.67 | 0.34 |
EV/FCF Ratio | -1.59 | - | 1.10 | 0.03 | 0.48 | 0.30 |
Debt / Equity Ratio | 0.04 | 0.04 | 0.05 | 0.04 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.44 | 0.44 | 0.38 | 0.29 | 0.01 | 0.02 |
Debt / FCF Ratio | 0.34 | 0.34 | 0.42 | 0.38 | 0.01 | 0.02 |
Net Debt / Equity Ratio | -0.90 | -0.90 | -0.82 | -0.80 | -0.79 | -0.71 |
Net Debt / EBITDA Ratio | -9.78 | -9.78 | -6.90 | -5.51 | -5.68 | -5.95 |
Net Debt / FCF Ratio | -7.43 | -7.43 | -7.47 | -7.12 | -5.14 | -6.88 |
Asset Turnover | 0.30 | 0.30 | 0.39 | 0.51 | 0.51 | 0.45 |
Inventory Turnover | 1.16 | 1.16 | 1.11 | 1.44 | 1.63 | 1.58 |
Quick Ratio | 3.42 | 3.42 | 3.17 | 2.97 | 3.66 | 4.62 |
Current Ratio | 3.71 | 3.71 | 3.51 | 3.35 | 4.07 | 5.19 |
Return on Equity (ROE) | 12.23% | 12.23% | 11.59% | 14.45% | 11.77% | 9.52% |
Return on Assets (ROA) | 4.09% | 4.09% | 5.33% | 6.81% | 5.78% | 4.63% |
Return on Invested Capital (ROIC) | 61.86% | 47.62% | 44.71% | 54.89% | 36.93% | 20.95% |
Return on Capital Employed (ROCE) | 8.30% | 8.30% | 11.00% | 13.60% | 10.90% | 8.80% |
Earnings Yield | 16.70% | 16.27% | 12.26% | 19.45% | 14.25% | 13.13% |
FCF Yield | 17.12% | 16.69% | 12.02% | 15.81% | 19.33% | 14.37% |
Dividend Yield | 6.49% | 6.40% | 6.69% | 7.62% | 6.05% | 9.39% |
Payout Ratio | 37.37% | 37.37% | 48.56% | 32.73% | 33.45% | 81.39% |
Buyback Yield / Dilution | - | - | - | - | -0.03% | 0.21% |
Total Shareholder Return | 6.49% | 6.40% | 6.69% | 7.62% | 6.02% | 9.61% |